BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 12393282)

  • 1. New complex t(2;11;17)(p21;q23;q11), a variant form of t(2;11), associated with del(5)(q23q32) in myelodysplastic syndrome-derived acute myeloblastic leukemia.
    Yamamoto K; Nagata K; Morita Y; Inagaki K; Hamaguchi H
    Cancer Genet Cytogenet; 2002 Sep; 137(2):119-23. PubMed ID: 12393282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG).
    Jaju RJ; Haas OA; Neat M; Harbott J; Saha V; Boultwood J; Brown JM; Pirc-Danoewinata H; Krings BW; Müller U; Morris SW; Wainscoat JS; Kearney L
    Blood; 1999 Jul; 94(2):773-80. PubMed ID: 10397745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unbalanced translocation der(11)t(11;12)(q23;q13): a new recurrent cytogenetic aberration in myelodysplastic syndrome with a complex karyotype.
    Yamamoto K; Hato A; Minagawa K; Yakushijin K; Urahama N; Gomyo H; Sada A; Okamura A; Ito M; Matsui T
    Cancer Genet Cytogenet; 2004 Nov; 155(1):67-73. PubMed ID: 15527905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Del(5q) and MLL amplification in homogeneously staining region in acute myeloblastic leukemia: a recurrent cytogenetic association.
    Herry A; Douet-Guilbert N; Guéganic N; Morel F; Le Bris MJ; Berthou C; De Braekeleer M
    Ann Hematol; 2006 Apr; 85(4):244-9. PubMed ID: 16425025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia.
    Fleischman EW; Reshmi S; Frenkel MA; Konovalova WI; Guleva GP; Kulagina OE; Konstantinova LN; Tupitsyn NN; Rowley JD
    Genes Chromosomes Cancer; 1999 Feb; 24(2):151-5. PubMed ID: 9885982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistent t(8;21)(q22;q22) Translocation and 5q Deletion in Acute Myeloid Leukemia.
    Yamamoto K; Yakushijin K; Sanada Y; Kawamoto S; Matsuoka H; Minami H
    J Clin Exp Hematop; 2015; 55(3):181-5. PubMed ID: 26763368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients.
    Douet-Guilbert N; De Braekeleer E; Basinko A; Herry A; Gueganic N; Bovo C; Trillet K; Dos Santos A; Le Bris MJ; Morel F; Eveillard JR; Berthou C; De Braekeleer M
    Leukemia; 2012 Jul; 26(7):1695-7. PubMed ID: 22290067
    [No Abstract]   [Full Text] [Related]  

  • 9. dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.
    Wang P; Spielberger RT; Thangavelu M; Zhao N; Davis EM; Iannantuoni K; Larson RA; Le Beau MM
    Genes Chromosomes Cancer; 1997 Nov; 20(3):282-91. PubMed ID: 9365836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
    Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping deletion regions at 11q23 in myelodysplastic syndrome and chronic lymphocytic leukemia, characterized by a novel BAC probe set.
    Siew-Gek Lee A; Rudduck-Sivaswaren C; Khun-Hong Lie D; Li-Ming Chua C; Tien SL; Morsberger L; Griffin CA
    Cancer Genet Cytogenet; 2004 Sep; 153(2):151-7. PubMed ID: 15350305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q).
    Zhang R; Kim YM; Wang X; Li Y; Lu X; Sternenberger AR; Li S; Lee JY
    Int J Med Sci; 2015; 12(9):719-26. PubMed ID: 26392809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute leukaemia and myelodysplastic syndromes with chromosomal rearrangement involving 11q23 locus, but not
    Zuo W; Wang SA; DiNardo C; Yabe M; Li S; Medeiros LJ; Tang G
    J Clin Pathol; 2017 Mar; 70(3):244-249. PubMed ID: 27496968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbalanced translocation der(5;17) resulting in a TP53 loss as recurrent aberration in myelodysplastic syndrome and acute myeloid leukemia with complex karyotype.
    Warnstorf D; Bawadi R; Schienke A; Strasser R; Schmidt G; Illig T; Tauscher M; Thol F; Heuser M; Steinemann D; Davenport C; Schlegelberger B; Behrens YL; Göhring G
    Genes Chromosomes Cancer; 2021 Jun; 60(6):452-457. PubMed ID: 33486841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cytogenetics localizes two new breakpoints on 11q23.3 and 21q11.2 in myelodysplastic syndrome with t(11;21) translocation.
    Wlodarska I; Selleri L; La Starza R; Paternotte C; Evans GA; Boogaerts M; Van den Berghe H; Mecucci C
    Genes Chromosomes Cancer; 1999 Mar; 24(3):199-206. PubMed ID: 10451699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia.
    Xu W; Li JY; Liu Q; Zhu Y; Pan JL; Qiu HR; Xue YQ
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e86-95. PubMed ID: 20089000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of 16q11 is a recurrent cytogenetic aberration in acute myeloblastic leukemia during disease progression.
    Yamamoto K; Nagata K; Kida A; Hamaguchi H
    Cancer Genet Cytogenet; 2001 Nov; 131(1):65-8. PubMed ID: 11734321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
    Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
    Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new nonrandom unbalanced t(17;20) in myeloid malignancies.
    Patsouris C; Michael PM; Campbell LJ
    Cancer Genet Cytogenet; 2002 Oct; 138(1):32-7. PubMed ID: 12419582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel translocation t(3;22)(q21;q11) involving 3q21 in myelodysplastic syndrome-derived overt leukemia with thrombocytosis.
    Yamamoto K; Nagata K; Tsurukubo Y; Morishita K; Hamaguchi H
    Leuk Res; 2000 May; 24(5):453-7. PubMed ID: 10785268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.